| Breast Cancer |
1 |
1 |
| Breast |
0 |
0.65 |
| Cancer |
0 |
0.65 |
| Endometrial Cancer |
0 |
0.58 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.58 |
| Genomic Medicine |
0 |
0.57 |
| Palliative Care |
0 |
0.55 |
| Cancer Risk |
0 |
0.51 |
| Gastric Cancer |
0 |
0.49 |
| Lobular Carcinoma |
0 |
0.49 |
| Advanced Cancer |
0 |
0.46 |
| Selective Estrogen Receptor Modulators |
0 |
0.25 |
| Preventive Screening |
0 |
0.21 |
| Clinical Guidelines |
0 |
0.17 |
| Mammogram |
0 |
0.17 |
| Thromboembolism |
0 |
0.14 |
| Genetic Testing |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Artificial Intelligence |
0 |
0.07 |
| Cerebrovascular Accident |
0 |
0.07 |
| Fractures |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Radiation Therapy |
0 |
0.07 |
| Thorax |
0 |
0.07 |
| Aesthetic Medicine |
0 |
0.06 |
| Deep Venous Thrombosis |
0 |
0.06 |
| Spinal Fractures and Dislocations |
0 |
0.06 |
| Bilateral Mastectomy |
0 |
0.05 |
| Fanconi Anemia |
0 |
0.05 |
| Neurofibromatosis Type 1 |
0 |
0.05 |
| Thrombus |
0 |
0.05 |
| Hodgkin Lymphoma |
0 |
0.04 |
| Anemia |
0 |
0.03 |
| Aromatase Inhibitors |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Clinical Management |
0 |
0.03 |
| Continuing Medical Education |
0 |
0.03 |
| Cowden Syndrome |
0 |
0.03 |
| Estrogen |
0 |
0.03 |
| Li-Fraumeni Syndrome |
0 |
0.03 |
| Magnetic Resonance Imaging |
0 |
0.03 |
| Mastectomy |
0 |
0.03 |
| Neurofibromatosis |
0 |
0.03 |
| Peutz-Jeghers Syndrome |
0 |
0.03 |
| Receptors |
0 |
0.03 |
| Spine |
0 |
0.03 |
| Thrombosis |
0 |
0.03 |
| Tumor |
0 |
0.03 |
| Vein |
0 |
0.03 |